Real-time enrollment status for this non-small cell lung cancer (nsclc) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:14 PM UTC
| NCT Number | NCT06128551 |
| Recruiting Status | Recruiting |
| Condition | Non-Small Cell Lung Cancer (NSCLC) |
| Phase | PHASE1 |
| Target Enrollment | 534 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Revolution Medicines, Inc. |
| Last Updated on CT.gov | August 3, 2026 (3 weeks ago) |
As of August 27, 2026: Clinical trial NCT06128551 is currently recruiting participants. This phase1 study for non-small cell lung cancer (nsclc) is actively seeking new participants at 23 locations across the United States. The study is sponsored by Revolution Medicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06128551 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06128551 was last updated 3 weeks ago (August 3, 2026). HelloStudys verifies this status automatically.